JPS57159712A - Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug - Google Patents

Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug

Info

Publication number
JPS57159712A
JPS57159712A JP4307381A JP4307381A JPS57159712A JP S57159712 A JPS57159712 A JP S57159712A JP 4307381 A JP4307381 A JP 4307381A JP 4307381 A JP4307381 A JP 4307381A JP S57159712 A JPS57159712 A JP S57159712A
Authority
JP
Japan
Prior art keywords
sempervirine
alstonine
serpentine
drug
activity against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4307381A
Other languages
Japanese (ja)
Inventor
Berujiyansuki Miruko
Bujie Jiyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP4307381A priority Critical patent/JPS57159712A/en
Publication of JPS57159712A publication Critical patent/JPS57159712A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4307381A 1981-03-24 1981-03-24 Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug Pending JPS57159712A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4307381A JPS57159712A (en) 1981-03-24 1981-03-24 Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4307381A JPS57159712A (en) 1981-03-24 1981-03-24 Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug

Publications (1)

Publication Number Publication Date
JPS57159712A true JPS57159712A (en) 1982-10-01

Family

ID=12653668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4307381A Pending JPS57159712A (en) 1981-03-24 1981-03-24 Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug

Country Status (1)

Country Link
JP (1) JPS57159712A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112964A1 (en) * 2004-05-19 2005-12-01 Natural Source International Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450607A2 (en) * 1978-03-13 1980-10-03 Beljanski Mirko Antiviral, anticancer, antitumour flavopereirine compsn. - activity tests for semperverine, serpentine and alstonine are also given

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450607A2 (en) * 1978-03-13 1980-10-03 Beljanski Mirko Antiviral, anticancer, antitumour flavopereirine compsn. - activity tests for semperverine, serpentine and alstonine are also given

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112964A1 (en) * 2004-05-19 2005-12-01 Natural Source International Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
JP2007538093A (en) * 2004-05-19 2007-12-27 ナチュラル ソース インターナショナル Combination of flavopereirin and alstonine in the treatment and prevention of prostate cancer
US7341749B2 (en) * 2004-05-19 2008-03-11 Natural Source International Ltd. Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer

Similar Documents

Publication Publication Date Title
AU547007B2 (en) Percutaneous drug therapy with skin permeability enhancer
GB2158829B (en) Human tumor necrosis factor and dna therefor
NZ223372A (en) Drug-containing jellifiable pellets
EP0659209A4 (en) Cancer therapy utilizing malignant cells.
AU4595985A (en) Cancer treatment
EP0070906A4 (en) Human interferon-beta gene.
AU559983B2 (en) Platinum complexes, treatment of cancer
AU581555B2 (en) Tumor localization and therapy
JPS572296A (en) Platinum organic complex, manufacture and malignant tumor medicine
EP0216938A4 (en) Hydrotreatment catalyst.
NO862353L (en) HUMAN TUMOR CANCER FACTOR.
JPS57192366A (en) Acylquinolinone derivative, manufacture, drug blend containing same and use
AU588862B2 (en) Human tumor therapy
AR242389A1 (en) Imidazoquinazoline derivatives, their preparation and medicaments containing them
AU5912886A (en) Tumor treatment in warm-blooded animals
EP0204831A4 (en) Therapeutic agent delivery system.
GB8527159D0 (en) Tumour therapy
DE3279834D1 (en) 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
JPS57159712A (en) Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug
JPS57165307A (en) Vermicides, manufacture and use
EP0345356A4 (en) Platinum complex and therapeutic agent for malignant tumor
GB2172558B (en) Co-ordinative rotatable supports.
IL79350A0 (en) Triazole derivatives,their manufacture and their use as pesticides
JPS55151515A (en) Cancer treating drug and its manufacture
ZA857906B (en) Human tumor necrosis factor